KGK Synergize Receives Multi-Site ISO 9001:2000 Certification
KGK Synergize Inc. (KGK) today announced the achievement of registration of its quality management system, ISO 9001:2000 (#CA05/3474), an international standard published by the International Organization for Standardization (ISO).
London, Ont. -- June 1, 2005 - KGK Synergize Inc. (KGK) today announced the achievement of registration of its quality management system, ISO 9001:2000 (#CA05/3474), an international standard published by the International Organization for Standardization (ISO). The accredited registrar, SGS Systems & Services Certification Canada Inc., confirmed KGK's compliance through a formal audit process. The scope of registration is as follows: "The provision of laboratory testing, analytical services, pre-clinical trials and the establishment of protocols and methods for food products, nature, and the nutraceutical and pharmaceutical product industries in accordance with standard good laboratory practices".
"This important accreditation indicates the on-going dedication of our employees to continuously measure and improve the various processes at KGK, in an effort to present our clients with the best possible customer service available at a research organization", states Robert A. Guthrie, V.P., Contract Research Services Division. "KGK is dedicated to reacting to the needs of our consumers and ISO will enable us to monitor, track and record those needs accordingly".
KGK Synergize provides contract research services in the areas of nutraceutical research, analytical chemistry, immunology, toxicology, autoimmune diseases, etc. and clinical trials.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
